abstract |
The invention relates to the fields of molecular biology and medicine, more specifically the invention is directed towards the treatment, delay, prevention or diagnosing of eating disorders, overweight, obesity or metabolic syndrome. More in particular, the invention provides a method for treating delaying or preventing an eating disorder wherein microRNA 216a or the complement thereof is administered to a subject in need of such a treatment. |